glp-1 and afib Can receptor agonists help reduce risk? While traditionally used for type 2 diabetes weight loss, GLP-1 RAs may offer benefits in atrial remodeling and AFib risk reduction. As cardiometabolic GLP-1 drugs outperform SGLT-2 drugs

Glutathione and NAD+ the Dynamic Duo of Nutrients Glutathione and NAD+ are both powerful nutrients found in every cell in your body that play a key role in human metabolism

In this matter, astrocytes are essential for the regulation of oxidative stress and ROS production, both in normal and in pathological circumstances

The question of whether GLP-1 receptor agonists might increase pancreatic cancer risk emerged from preclinical animal studies and early post-marketing surveillance reports

One reason KPV is interesting is its targeting

Afr J Pharm Pharmacol 5:10541060 Antonowicz J, Andrzejak R, Lepetow T (1998) Influence of heavy metals, especially lead, on lipid metabolism, serum alpha-tocopherol level, total antioxidant status, and erythrocyte redox status of copper smelter workers

FDA website